|
PF-00446687
|
DB12517 |
[PF-00446687 has been investigated for the treatment of Erectile Dysfunction.] |
|
Fluorodopa (18F)
|
DB13848 |
|
|
Raclopride
|
DB12518 |
[Raclopride has been used in trials studying Parkinson Disease.] |
|
Clofibride
|
DB13849 |
|
|
Sarcosine
|
DB12519 |
[Sarcosine has been investigated for the treatment of Schizophrenia.] |
|
Omaveloxolone
|
DB12513 |
[Omaveloxolone has been used in trials studying the treatment of Relapsed, Refractory Melanoma and Metastatic or Incurable Non-small Cell Lung Cancer.] |
|
Pipenzolate
|
DB13844 |
|
|
Etafenone
|
DB13845 |
[Etafenone is a vasodilator.] |
|
Iofolastat I-123
|
DB12514 |
[Iofolastat I-123 is under investigation in clinical trial NCT00992745 (A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer).] |
|
Pyrrobutamine
|
DB13846 |
|
|
9-aminocamptothecin
|
DB12515 |
[Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others.] |
|
Rhenium Re-186 sulfide
|
DB13847 |
|
|
Hydroxyethylpromethazine
|
DB13840 |
|
|
Ozone
|
DB12510 |
[Ozone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite.] |
|
Clopenthixol
|
DB13841 |
[Clopenthixol is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.] |
|
Imiglitazar
|
DB12511 |
[Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.] |
|
Etofylline nicotinate
|
DB13842 |
[Etofylline nicotinate, a theophylline derivative, is a drug that causes vasodilation and relaxation of smooth muscle.] |
|
Cloprednol
|
DB13843 |
[Cloprednol is a synthetic glucocorticoid that has been investigated for use in the treatment of asthma. [A31775,A31776]] |
|
Verucerfont
|
DB12512 |
[Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia.] |
|
Toremifene
|
DB00539 |
[A first generation nonsteroidal selective estrogen receptor modulator (SERM) that is structurally related to tamoxifen. Like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.] |